Price target upside
Sutro Biopharma, Inc. Price Target Upside or Downside
STRO price target upside based on the current price and analyst average.
Direct answer
Sutro Biopharma, Inc.'s analyst target implies +147.8%.
The average target is $47.77 compared with a recorded current price of $19.28.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Sutro Biopharma, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $19.28
- Average price target
- $47.77
- High price target
- $61.00
- Low price target
- $10.00
- Target upside
- +147.8%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026